Renu Virmani Selected Research

Sudden Death

7/2023	Polygenic Risk Score Associates with Atherosclerotic Plaque Characteristics at Autopsy.
12/2012	Differential expression of oxidation-specific epitopes and apolipoprotein(a) in progressing and ruptured human coronary and carotid atherosclerotic lesions.
5/2011	Autopsy validation study of the academic research consortium stent thrombosis definition.
2/2006	Identification of novel missense mutations of cardiac ryanodine receptor gene in exercise-induced sudden death at autopsy.
12/2004	Decorin promotes aortic smooth muscle cell calcification and colocalizes to calcified regions in human atherosclerotic lesions.
11/2002	Increased serum homocysteine and sudden death resulting from coronary atherosclerosis with fibrous plaques.
7/2002	Sudden death following rupture of a right ventricular aneurysm 9 months after ablation therapy of the right ventricular outflow tract.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Renu Virmani Research Topics

Disease

99	Thrombosis (Thrombus) 11/2022 - 02/2002
61	Atherosclerotic Plaque (Atheroma) 12/2023 - 04/2002
60	Inflammation (Inflammations) 03/2023 - 02/2002
54	Atherosclerosis 01/2024 - 04/2002
37	Coronary Artery Disease (Coronary Atherosclerosis) 01/2024 - 08/2001
33	Pathologic Constriction (Stenosis) 10/2023 - 06/2002
32	Rupture 01/2022 - 04/2002
20	Neointima 01/2020 - 02/2002
19	Myocardial Infarction 02/2023 - 10/2003
19	Hemorrhage 02/2023 - 12/2003
16	Acute Coronary Syndrome 04/2023 - 10/2003
15	Hyperplasia 11/2016 - 02/2002
14	Hypersensitivity (Allergy) 01/2018 - 01/2004
13	Hypertension (High Blood Pressure) 01/2023 - 01/2002
13	Necrosis 02/2018 - 12/2003
10	Cardiovascular Diseases (Cardiovascular Disease) 11/2019 - 10/2003
9	Aneurysm (Aneurysms) 08/2023 - 07/2002
9	Ischemia 12/2018 - 02/2007
9	Infarction (Infarctions) 12/2018 - 01/2002
7	AIDS-Related Complex (ARC) 12/2023 - 05/2011
7	Sudden Death 07/2023 - 07/2002
7	ST Elevation Myocardial Infarction 08/2021 - 03/2013
7	Coronary Thrombosis 02/2007 - 04/2002
6	Coronary Disease (Coronary Heart Disease) 01/2024 - 11/2002
6	Stroke (Strokes) 11/2023 - 01/2016
5	Vascular Calcification 11/2023 - 12/2004
5	Neoplasms (Cancer) 01/2021 - 12/2002
5	Fibrosis (Cirrhosis) 06/2014 - 01/2002
4	COVID-19 09/2023 - 01/2021
4	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2018 - 10/2003
4	Aortic Valve Stenosis (Aortic Stenosis) 01/2018 - 01/2016
4	Vascular Diseases (Vascular Disease) 01/2017 - 02/2004
3	Intracranial Embolism 01/2018 - 10/2012
3	Calcinosis 01/2018 - 08/2015
3	Diabetes Mellitus 01/2017 - 08/2014
3	Vascular Remodeling 09/2016 - 07/2007
3	Disease Progression 08/2015 - 09/2008
3	Coronary Occlusion 01/2012 - 12/2006
2	Peripheral Arterial Disease 01/2023 - 01/2019
2	Arterial calcification of infancy 01/2022 - 09/2018

Drug/Important Bio-Agent (IBA)

41	LipidsIBA 01/2024 - 01/2002
27	Phenobarbital (Luminal)FDA Link 01/2023 - 02/2002
26	PolymersIBA 08/2023 - 11/2002
24	MetalsIBA 03/2019 - 10/2003
23	FibrinIBA 03/2023 - 02/2002
20	CholesterolIBA 04/2023 - 01/2002
20	Sirolimus (Rapamycin)FDA Link 08/2014 - 10/2003
14	Everolimus FDA Link 06/2020 - 10/2002
14	Paclitaxel (Taxol)FDA LinkGeneric 02/2018 - 07/2005
12	Biomarkers (Surrogate Marker)IBA 01/2024 - 11/2006
12	Proteoglycans (Proteoglycan)IBA 12/2023 - 02/2002
11	CalciumIBA 01/2024 - 01/2002
11	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2023 - 12/2005
11	CollagenIBA 01/2021 - 02/2002
6	omega-Chloroacetophenone (Mace)IBA 07/2021 - 10/2004
5	CytokinesIBA 12/2021 - 12/2010
5	Annexin A5IBA 12/2018 - 12/2003
5	Apolipoproteins E (ApoE)IBA 01/2016 - 09/2006
5	zotarolimusIBA 01/2012 - 06/2005
4	Fluorocarbon PolymersIBA 01/2023 - 09/2017
4	Proteins (Proteins, Gene)FDA Link 12/2021 - 12/2003
4	IronIBA 09/2019 - 12/2003
4	ApolipoproteinsIBA 01/2016 - 09/2006
4	Hyaluronic Acid (Hyaluronan)IBA 08/2015 - 10/2002
3	Indicators and Reagents (Reagents)IBA 01/2024 - 06/2010
3	BiglycanIBA 12/2023 - 10/2002
3	PlatinumIBA 08/2023 - 11/2009
3	Pancreatic Elastase (Elastase)IBA 08/2023 - 11/2009
3	AlbuminsIBA 01/2023 - 11/2002
3	oxidized low density lipoproteinIBA 01/2022 - 01/2019
3	EpitopesIBA 01/2022 - 01/2012
3	AntibodiesIBA 01/2022 - 02/2004
3	LigandsIBA 12/2021 - 07/2004
3	Phosphotransferases (Kinase)IBA 12/2021 - 01/2016
3	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 02/2014
3	LeptinIBA 01/2016 - 10/2012
3	Versicans (Versican)IBA 08/2015 - 10/2002
3	C-Reactive ProteinIBA 07/2014 - 04/2002
3	Lipoproteins (Lipoprotein)IBA 06/2014 - 01/2012
3	Matrix Metalloproteinases (MMPs)IBA 06/2013 - 09/2009
3	Phospholipids (Phosphatides)FDA LinkGeneric 12/2012 - 10/2005
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2010 - 02/2007
3	HDL CholesterolIBA 02/2010 - 01/2002
3	Metalloproteases (Metalloproteinases)IBA 09/2009 - 07/2003
3	Collagen Type I (Type I Collagen)IBA 12/2004 - 10/2002
3	DecorinIBA 12/2004 - 10/2002
2	Hemoglobins (Hemoglobin)IBA 06/2022 - 01/2012
2	TOR Serine-Threonine KinasesIBA 01/2020 - 01/2018

Therapy/Procedure

123	Stents 03/2023 - 02/2002
45	Drug-Eluting Stents 01/2022 - 01/2004
40	Therapeutics 12/2023 - 08/2001
21	Percutaneous Coronary Intervention 10/2022 - 10/2004
7	Catheters 01/2023 - 12/2002
6	Transcatheter Aortic Valve Replacement 11/2023 - 04/2015
4	Carotid Endarterectomy 01/2023 - 08/2006
4	Denervation 01/2021 - 10/2013
3	Lithotripsy (Extracorporeal Shockwave Lithotripsy) 11/2023 - 01/2021
3	Thrombectomy 09/2023 - 03/2013
3	Radiotherapy 01/2021 - 12/2002
2	Drug Therapy (Chemotherapy) 01/2020 - 07/2009